Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Mining Genomic Literature for Variant Interpretation and Gene Panel Design

Creating an evidence-based gene panel with prioritized literature citations for each biomarker

Third Party Component Operational Aspects of PDL1 Stratification and...

Immuno-Oncology 360° Conference Presentation

Biomarker roadmap to success

Develop a biomarker roadmap for a successful strategy in developing targeted therapies

A Pan-Cancer view of gene expression in Immuno-Oncology with particular...

Advantages of RNA-Seq for measurement of immune response

Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials

Genomic technologies that empower and enhance immuno-oncology trials

Fighting Cancer Biomarkers for Immuno-Oncology Clinical Trials

Using anatomic pathology for biomarker development in clinical trials can help predict and assess...

Best Practices for Integrating Biomarkers across the Drug Development...

A roadmap for a successful biomarker strategy

Validating Flow Cytometry Assays for Immuno Oncology Trials in the Central...

Molecular Medicine Tri-Conference 2017

The End to End Importance of Selecting the Right Biomarker in Cancer...

Fighting Cancer: Biomarkers for Immuno-Oncology Clinical Trials

Companion Diagnostic Development: Current trends and recommendations

Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach